Promising New Diagnostic for Emphysema

Dr. Crystal and researchers in the Weill Cornell Medical College Department of Genetic Medicine have located a potential biomarker of early-stage emphysema. Although further investigation is needed, these findings are promising for early detection of emphysema by a simple blood test.

Please click here to see the full article

Click here to read the abstract in the American Journal of Respiratory and Critical Care Medicine

Advertisements

Dr. Crystal and the Dept. of Genetic Medicine Featured on NY1 TV

Researchers at Weill Cornell Medical College seem to have made a revolutionary discovery that may inspire more smokers to put out their butts a lot faster.” –NY1

Dr. Ronald Crystal (Chairman of Genetic Medicine at Weill Cornell Medical College and Principal Investigator) was featured on NY1 television to talk about how a simple blood test may detect signs of emphysema, or lung damage, before symptoms develop in smokers. Smoking is the main cause of lung disease, such as Chronic Obstructive Pulmonary Disease (COPD) and emphysema. This simple blood test, is still under investigation; however, Dr. Crystal and researchers in the Department of Genetic Medicine hope that this blood test will help smokers detect signs of emphysema and inspire them to quit before it is too late.

Watch the video

Read the full article by NY1

%d bloggers like this: